Literature DB >> 15667475

Exogenous glucocorticoid excess as a result of ritonavir-fluticasone interaction.

G Soldatos, S Sztal-Mazer, I Woolley, J Stockigt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15667475     DOI： 10.1111/j.1445-5994.2004.00723.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN： 1444-0903            Impact factor:   2.048


× No keyword cloud information.
  6 in total

1.  Secondary Adrenal Insufficiency Due to the Co-Administration of Ritonavir and Inhaled Fluticasone Propionate: Case report.

Authors:  Ali Al-Maqbali; Bina Kamble; Salim Al-Qassabi; Ali Elgalib
Journal:  Sultan Qaboos Univ Med J       Date:  2017-10-10

2.  Influence of low-dose ritonavir with and without darunavir on the pharmacokinetics and pharmacodynamics of inhaled beclomethasone.

Authors:  Sarita D Boyd; Colleen Hadigan; Maryellen McManus; Cheryl Chairez; Lynnette K Nieman; Alice K Pau; Raul M Alfaro; Joseph A Kovacs; Monica M Calderon; Scott R Penzak
Journal:  J Acquir Immune Defic Syndr       Date:  2013-07-01       Impact factor: 3.731

3.  Use of rosuvastatin in HIV-associated chronic obstructive pulmonary disease.

Authors:  Alison Morris; Meghan Fitzpatrick; Marnie Bertolet; Shulin Qin; Lawrence Kingsley; Nicolas Leo; Cathy Kessinger; Heather Michael; Deborah Mcmahon; Renee Weinman; Stephen Stone; Joseph K Leader; Eric Kleerup; Laurence Huang; Stephen R Wisniewski
Journal:  AIDS       Date:  2017-02-20       Impact factor: 4.177

Review 4.  Inhaled corticosteroid use in HIV-positive individuals taking protease inhibitors: a review of pharmacokinetics, case reports and clinical management.

Authors:  P Saberi; T Phengrasamy; D P Nguyen
Journal:  HIV Med       Date:  2013-04-16       Impact factor: 3.180

5.  Influence of antiretroviral drugs on the pharmacokinetics of prednisolone in HIV-infected individuals.

Authors:  Kristin H Busse; Elizabeth Formentini; Raul M Alfaro; Joseph A Kovacs; Scott R Penzak
Journal:  J Acquir Immune Defic Syndr       Date:  2008-08-15       Impact factor: 3.731

6.  Iatrogenic Cushing syndrome and adrenal insufficiency during concomitant therapy with ritonavir and fluticasone.

Authors:  Narendranath Epperla; Fergus McKiernan
Journal:  Springerplus       Date:  2015-08-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.